科学健康资讯 · 内容仅供参考,不替代专业诊疗 联系我们|疾病百科
操作系统

syros医药(syrs)

2023-05-09 操作系统 本文链接

Syros医药(SYRS):

Syros医药(SYRS) 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-23-005702  Act: 34  Size: 17 MB 网页链接

Syros医药(SYRS):

Syros医药(SYRS) SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-23-033116  Act: 34  Size: 140 KB 网页链接

Syros医药(SYRS):

Syros医药(SYRS) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-011165  Size: 5 KB 网页链接

Syros医药(SYRS):

Syros医药(SYRS) S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-23-057345  Act: 33  Size: 68 KB 网页链接

Syros医药(SYRS):

Syros医药(SYRS) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-011162  Size: 5 KB 网页链接

Syros医药(SYRS):

Syros医药(SYRS) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-011170  Size: 5 KB 网页链接

Syros医药(SYRS):

Syros医药(SYRS) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-011151  Size: 5 KB 网页链接

Syros医药(SYRS):

Syros医药(SYRS) SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000919574-23-001654  Act: 34  Size: 179 KB 网页链接

Syros医药(SYRS):

Syros医药(SYRS) SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-23-036933  Act: 34  Size: 97 KB 网页链接

Syros医药(SYRS):

Syros医药(SYRS) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-011157  Size: 5 KB 网页链接

Syros医药(SYRS):

Syros医药(SYRS) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-011167  Size: 5 KB 网页链接

Syros医药(SYRS):

Syros医药(SYRS) 8-K Current report, item 7.01 Accession Number: 0001193125-23-067652  Act: 34  Size: 141 KB 网页链接

本文内容仅供健康科普参考,不能替代专业医疗诊断和治疗建议。如有身体不适,请及时就医并遵从医师指导。

相关阅读